Education
About Us
Working with TipRanks
Follow Us
Kraig Biocraft Laboratories (KBLB)
:KBLB
RESEARCH TOOLSreports
Total Valuation
Kraig Biocraft Laboratories has a market cap or net worth of $86.94M. The enterprise value is $93.87M.
Market Cap$86.94M
Enterprise Value$93.87M
Share Statistics
Kraig Biocraft Laboratories has 1,047,526,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,047,526,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kraig Biocraft Laboratories’s return on equity (ROE) is 417.07K and return on invested capital (ROIC) is 31.98%.
Return on Equity (ROE)417.07K
Return on Assets (ROA)-2.26M
Return on Invested Capital (ROIC)31.98%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee0.00
Profits Per Employee-91.86K
Employee Count37
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Kraig Biocraft Laboratories is >-0.01. Kraig Biocraft Laboratories’s PEG ratio is -1.72.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio-10.97
Price to Fair Value-11.82
Price to FCF-40.97
Price to Operating Cash Flow-52.54
PEG Ratio-1.72
Income Statement
In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.40T in profits. Earnings per share was -3.27K.
Revenue0.00
Gross Profit0.00
Operating Income-3.07T
Pretax Income-3.40T
Net Income-3.40T
EBITDA-3.07T
Earnings Per Share (EPS)-3.27K
Cash Flow
In the last 12 months, operating cash flow was -1.78M and capital expenditures -4.24K, giving a free cash flow of -2.30M billion.
Operating Cash Flow-1.78M
Free Cash Flow-2.30M
Free Cash Flow per Share>-0.01
Dividends & Yields
Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-27.27%
50-Day Moving Average0.08
200-Day Moving Average0.09
Relative Strength Index (RSI)43.82
Average Volume (3m)503.10K
Important Dates
Kraig Biocraft Laboratories upcoming earnings date is Aug 10, 2023, TBA Not Confirmed.
Last Earnings DateMay 12, 2023
Next Earnings DateAug 10, 2023
Ex-Dividend Date―
Financial Position
Kraig Biocraft Laboratories as a current ratio of <0.01, with Debt / Equity ratio of -0.86%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.02
Net Debt to EBITDA-0.03
Interest Coverage Ratio5.81
Taxes
In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Kraig Biocraft Laboratories EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -47.51K.
EV to Sales0.00
EV to EBITDA-0.03
EV to Free Cash Flow-47.51K
EV to Operating Cash Flow-47.62K
Balance Sheet
Kraig Biocraft Laboratories has $397.00K in cash and marketable securities with $73.27K in debt, giving a net cash position of -$323.73K billion.
Cash & Marketable Securities$397.00K
Total Debt$73.27K
Net Cash-$323.73K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 25.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin25.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―